Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Poliorix booster study in Chinese toddlers previously primed in IPV-018
2012-004513-14Phase 3
- Sponsor
- GSK
- Start
- May 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Poliorix in poliomyelitis, sponsored by GSK. Primary endpoints: Anti-poliovirus types 1, 2 and 3 seroprotection status and Anti-poliovirus types 1, 2 and 3 antibody titres.
02
Drugs
Poliorix
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on 2012-004513-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004513-14.